Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis
- 1 May 1999
- journal article
- case report
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 165 (1) , 56-61
- https://doi.org/10.1016/s0022-510x(99)00072-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Acute Disseminated Encephalomyelitis: Response to Intravenous Immunoglobulin?Journal of Child Neurology, 1995
- High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.Journal of Clinical Investigation, 1994
- Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Anti‐Cytokine Nature of Natural Human Immunoglobulin: One Possible Mechanism of the Clinical Effect of Intravenous Immunoglobulin TherapyImmunological Reviews, 1994
- Binding of cytokines to pharmaceutically prepared human immunoglobulin.Journal of Clinical Investigation, 1993
- Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies.Journal of Clinical Investigation, 1990
- Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model.Journal of Clinical Investigation, 1989
- Comparison of intravenous gamma globulin and a monoclonal anti-Fc receptor antibody as inhibitors of immune clearance in vivo in mice.Journal of Clinical Investigation, 1986
- Reversible and irreversible loss of Fc receptor function of human monocytes as a consequence of interaction with immunoglobulin G.Journal of Clinical Investigation, 1980
- Disseminated vasculomyelinopathy: An immune complex diseaseAnnals of Neurology, 1980